Dogwood Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +1.4% | -286.7% | – | – | -0.9% | – | |
| – | +0.0% | -6.3% | +7.2% | -36.7% | -0.5% | -9.9% | -23.0% | -25.8% | +227.0% | +184.7% | +20.9% | – | |
| – | -507.2% | – | -58.5% | +1,331.7% | -269.4% | – | – | – | -87.8% | -354.6% | – | – | |
| – | – | – | – | -25.0% | -100.0% | – | -100.0% | – | -100.0% | – | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | |
| – | -100.0% | – | – | -104.8% | – | -51.9% | -101.6% | -100.0% | – | +34,577.5% | -100.0% | – | |
| – | -849.6% | – | – | -253.0% | – | -79.0% | -253.7% | – | – | – | -154.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.